Patents Assigned to NEURIM PHARMACEUTICALS LTD.
  • Melatonin mini-tablets and method of manufacturing the same
    Patent number: 10869857
    Abstract: The instant invention is generally directed to a patient-friendly drug delivery system for targeted populations, such as pediatric and geriatric patients. Specifically, the present invention relates to a pharmaceutical composition in the form of mini-tablets. Even more specifically, the present invention relates to a pharmaceutical composition comprising a therapeutically-effective amount of melatonin in the form of mini-tablets.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: December 22, 2020
    Assignee: Neurim Pharmaceuticals Ltd.
    Inventors: Moshe Laudon, Nava Zisapel
  • Melatonin mini-tablets and method of manufacturing the same
    Patent number: 10849856
    Abstract: A patient-friendly drug delivery system and method for targeted populations, such as pediatric and geriatric patients is provided, which system and method include a pharmaceutical composition in the form of mini-tablets. A method of inducing and maintaining sleep in a human in need thereof with the mini-tablets is provided. A method of manufacturing mini-tablets is provided.
    Type: Grant
    Filed: June 16, 2020
    Date of Patent: December 1, 2020
    Assignee: Neurim Pharmaceuticals Ltd.
    Inventors: Moshe Laudon, Nava Zisapel
  • MELATONIN MINI-TABLETS AND METHOD OF MANUFACTURING THE SAME
    Publication number: 20200306193
    Abstract: A patient-friendly drug delivery system and method for targeted populations, such as pediatric and geriatric patients is provided, which system and method include a pharmaceutical composition in the form of mini-tablets. A method of inducing and maintaining sleep in a human in need thereof with the mini-tablets is provided. A method of manufacturing mini-tablets is provided.
    Type: Application
    Filed: June 16, 2020
    Publication date: October 1, 2020
    Applicant: NEURIM PHARMACEUTICALS LTD.
    Inventors: Moshe LAUDON, Nava ZISAPEL
  • MELATONIN MINI-TABLETS AND METHOD OF MANUFACTURING THE SAME
    Publication number: 20200306227
    Abstract: The instant invention is generally directed to a patient-friendly drug delivery system for targeted populations, such as pediatric and geriatric patients. Specifically, the present invention relates to a pharmaceutical composition in the form of mini-tablets. Even more specifically, the present invention relates to a pharmaceutical composition comprising a therapeutically-effective amount of melatonin in the form of mini-tablets.
    Type: Application
    Filed: June 16, 2020
    Publication date: October 1, 2020
    Applicant: NEURIM PHARMACEUTICALS LTD.
    Inventors: Moshe LAUDON, Nava ZISAPEL
  • Melatonin mini-tablets and method of manufacturing the same
    Patent number: 10722494
    Abstract: The instant invention is generally directed to a patient-friendly drug delivery system for targeted populations, such as pediatric and geriatric patients. Specifically, the present invention relates to a pharmaceutical composition in the form of mini-tablets. Even more specifically, the present invention relates to a pharmaceutical composition comprising a therapeutically-effective amount of melatonin in the form of mini-tablets.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: July 28, 2020
    Assignee: Neurim Pharmaceuticals Ltd.
    Inventors: Moshe Laudon, Nava Zisapel
  • MELATONIN MINI-TABLETS AND METHOD OF MANUFACTURING THE SAME
    Publication number: 20190060277
    Abstract: The instant invention is generally directed to a patient-friendly drug delivery system for targeted populations, such as pediatric and geriatric patients. Specifically, the present invention relates to a pharmaceutical composition in the form of mini-tablets. Even more specifically, the present invention relates to a pharmaceutical composition comprising a therapeutically-effective amount of melatonin in the form of mini-tablets.
    Type: Application
    Filed: October 31, 2018
    Publication date: February 28, 2019
    Applicant: NEURIM PHARMACEUTICALS LTD.
    Inventors: Moshe LAUDON, Nava ZISAPEL